Cameron E, Pauling L
Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer
Proc Natl Acad Sci U S A 1978 Sep;75(9):4538-42 (Clinical Study, Reference)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=279931&dopt=Abstract

Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
N Engl J Med 1979 Sep 27;301(13):687-90 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=384241&dopt=Abstract

Prasad KN, Cole WC, Kumar B, Prasad KC
Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies
J Am Coll Nutr 2001 Oct;20(5 Suppl):450S-463S (Review Article, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11603656&dopt=Abstract
Free full text article: http://www.jacn.org/cgi/content/full/20/suppl_5/450S

Prasad KN, Kumar A, Kochupillai V, Cole WC
High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy
J Am Coll Nutr 1999 Feb;18(1):13-25 (Review Article, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10067654&dopt=Abstract
Free full text article: http://www.jacn.org/cgi/content/full/18/1/13

Salganik RI
The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population
J Am Coll Nutr 2001 Oct;20(5 Suppl):464S-472SReview Article, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11603657&dopt=Abstract
Free full text article: http://www.jacn.org/cgi/content/full/20/suppl_5/464S

Salganik RI, Albright CD, Rodgers J, Kim J, Zeisel SH, Sivashinskiy MS, Van Dyke TA
Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice
Carcinogenesis 2000 May;21(5):909-14 (Cell Culture Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10783311&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://carcin.oupjournals.org/cgi/pmidlookup?view=full&pmid=10783311

Sun AS, Ostadal O, Ryznar V, Dulik I, Dusek J, Vaclavik A, Yeh HC, Hsu C, Bruckner HW, Fasy TM
Phase I/II study of stage III and IV non-small cell lung cancer patients taking a specific dietary supplement
Nutr Cancer 1999;34(1):62-9 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10453443&dopt=Abstract

Sun AS, Yeh HC, Wang LH, Huang YP, Maeda H, Pivazyan A, Hsu C, Lewis ER, Bruckner HW, Fasy TM
Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients
Nutr Cancer 2001;39(1):85-95 (Animal Study | Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11588907&dopt=Abstract

Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
Cancer Epidemiol Biomarkers Prev 2001 Aug;10(8):861-8 (Clinical Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11489752&dopt=Abstract
Free full text article: http://cebp.aacrjournals.org/cgi/content/full/10/8/861

Neri B, de Leonardis V, Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G
Melatonin as biological response modifier in cancer patients
Anticancer Res 1998 Mar-Apr;18(2B):1329-32 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9615811&dopt=Abstract

Lissoni P, Meregalli S, Nosetto L, Barni S, Tancini G, Fossati V, Maestroni G.
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
Oncology 1996 Jan-Feb;53(1):43-6 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8570130&dopt=Abstract

Lissoni P, Brivio O, Brivio F, Barni S, Tancini G, Crippa D, Meregalli S
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
J Pineal Res 1996 Nov;21(4):239-42 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8989723&dopt=Abstract

Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Meregalli S, Fossati V, Fumagalli L, Brivio F, Tancini G
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
Oncology 1995 May-Jun;52(3):243-5 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7715908&dopt=Abstract

Lissoni P, Paolorossi F, Ardizzoia A, Barni S, Chilelli M, Mancuso M, Tancini G, Conti A, Maestroni GJ
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
J Pineal Res 1997 Aug;23(1):15-9 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9379341&dopt=Abstract

Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K
Krestin (PSK)
Cancer Treat Rev 1984 Jun;11(2):131-55 (Clinical Study | Review Article, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6238674&dopt=Abstract

Kobayashi H, Matsunaga K, Oguchi Y
Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview
Cancer Epidemiol Biomarkers Prev 1995 Apr-May;4(3):275-81 (Review Article, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7606203&dopt=Abstract

Chihara G
Recent progress in immunopharmacology and therapeutic effects of polysaccharides
Dev Biol Stand 1992;77:191-7 (Clinical Study | Review Article, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1426662&dopt=Abstract

Hayakawa K, Mitsuhashi N, Saito Y, Takahashi M, Katano S, Shiojima K, Furuta M, Niibe H
Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer
Anticancer Res 1993 Sep-Oct;13(5C):1815-20 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8267386&dopt=Abstract